Authors
Loading...
Successful C-strain recombinants extend bivalent vaccine vector options; leaves open swine efficacy and safety validation.
Key points are not available for this paper at this time.
Zhang et al. (2017) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: